Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

On This Page: Biotech Stock Resources FAQ Why Invest in Biotech Stocks

Company	Current Price	P/E Ratio	Market Cap	Volume	Average Volume	Indicator(s)
ABBV AbbVie	$206.23 -0.2%	98.21	$365.13 billion	6.08 million	4.89 million	Positive News
TMO Thermo Fisher Scientific	$488.15 -0.2%	28.23	$184.66 billion	2.21 million	3.06 million	Positive News Analyst Forecast
DHR Danaher	$209.32 -0.8%	44.54	$151.04 billion	2.86 million	4.61 million	Positive News
VRTX Vertex Pharmaceuticals	$389.88 -0.7%	27.87	$100.71 billion	1.38 million	2.39 million	Positive News
GSK GSK	$39.05 -0.8%	18.08	$80.26 billion	2.44 million	4.59 million	Positive News
ALNY Alnylam Pharmaceuticals	$456.87 +1.8%	N/A	$58.84 billion	1.61 million	1.32 million	Positive News
COR Cencora	$290.45 -0.8%	29.88	$56.77 billion	1.19 million	1.23 million	Positive News
TAK Takeda Pharmaceutical	$15.18 +1.2%	50.61	$47.73 billion	3.56 million	5.50 million	News Coverage Positive News Short Interest ↑
VEEV Veeva Systems	$282.83 +0.8%	59.92	$45.86 billion	1.23 million	1.16 million	Positive News
ARGX argenex	$661.32 +1.1%	33.91	$40.01 billion	308,199	448,185	Positive News
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CTSH Cognizant Technology Solutions	$70.10 +0.1%	14.25	$34.19 billion	2.34 million	4.57 million	Positive News
IQV IQVIA	$192.58 +0.8%	27.87	$32.49 billion	1.34 million	2.20 million	Short Interest ↓
BNTX BioNTech	$112.55 -0.9%	N/A	$27.29 billion	398,931	688,783	Analyst Revision
RPRX Royalty Pharma	$35.92 -1.2%	20.76	$21.20 billion	2.39 million	2.94 million	Positive News
IFF International Flavors & Fragrances	$65.34 -0.7%	N/A	$16.87 billion	1.71 million	2.60 million	Positive News
ILMN Illumina	$100.53 +0.4%	12.73	$15.39 billion	1.21 million	2.17 million	Positive News
ICLR Icon	$178.56 +1.5%	18.37	$14.20 billion	867,373	1.69 million
UTHR United Therapeutics	$314.10 +0.3%	12.26	$14.12 billion	651,683	702,087	Positive News
SUZ Suzano	$9.73 -2.1%	8.61	$13.16 billion	1.81 million	2.04 million	Short Interest ↑
MEDP Medpace	$462.91 +1.1%	34.42	$12.86 billion	240,977	772,137	Positive News
FN Fabrinet	$326.47 -1.0%	36.36	$11.82 billion	1.20 million	572,930	Trending News Earnings Report High Trading Volume
MRNA Moderna	$28.09 +0.2%	N/A	$10.90 billion	6.14 million	8.65 million
BE Bloom Energy	$46.57 +2.8%	1,164.54	$10.60 billion	9.80 million	12.56 million
RVTY Revvity	$89.72 -1.2%	38.02	$10.54 billion	976,599	1.60 million	Positive News
LITE Lumentum	$118.98 +2.7%	517.30	$8.04 billion	2.97 million	2.96 million	Earnings Report Analyst Upgrade
CRL Charles River Laboratories International	$157.27 +0.4%	N/A	$7.71 billion	649,016	1.11 million	Positive News Analyst Downgrade
LEGN Legend Biotech	$37.45 -0.1%	N/A	$6.89 billion	702,700	1.13 million
BIO.B Bio-Rad Laboratories	$247.05	21.06	$6.72 billion	30	42	Positive News
IBB iShares Biotechnology ETF	$138.38 -0.3%	N/A	$5.67 billion	1.14 million	1.54 million	News Coverage
ABVX Abivax	$70.01 -0.6%	N/A	$5.32 billion	533,201	3.20 million	Short Interest ↑
TGTX TG Therapeutics	$27.73 -1.2%	74.95	$4.46 billion	2.36 million	2.82 million	Positive News
KRYS Krystal Biotech	$146.30 -2.6%	29.74	$4.35 billion	253,353	432,995	Positive News
PCVX Vaxcyte	$32.09 -1.9%	N/A	$4.25 billion	1.22 million	1.32 million
AAPG Ascentage Pharma Group International	$47.49 +5.6%	N/A	$4.18 billion	11,279	7,219	Gap Up
HTGC Hercules Capital	$19.10 +0.2%	12.65	$3.46 billion	1.12 million	1.16 million	Positive News
MENS Jyong Biotech	$41.50 -7.2%	N/A	$3.40 billion	172,851	136,916	Gap Down
ODD ODDITY Tech	$62.03 +3.2%	34.46	$3.36 billion	649,792	1.27 million	Positive News
TPC Tutor Perini	$57.41 +1.2%	N/A	$2.99 billion	455,579	771,258
RXRX Recursion Pharmaceuticals	$5.52 -4.3%	N/A	$2.51 billion	16.99 million	24.96 million	Positive News
SXI Standex International	$203.86 +0.7%	43.94	$2.44 billion	83,768	139,037	Short Interest ↑
BREAKING: The House just passed 3 pro-crypto bills! (Ad) THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result.
IBRX ImmunityBio	$2.43 -4.7%	N/A	$2.41 billion	12.13 million	9.31 million
FOLD Amicus Therapeutics	$7.41 +0.1%	N/A	$2.28 billion	3.77 million	4.53 million	Positive News
JTEK JPMorgan U.S. Tech Leaders ETF	$85.66 +0.4%	47.07	$2.16 billion	185,906	244,469	Positive News
DNLI Denali Therapeutics	$14.82 +0.8%	N/A	$2.15 billion	1.27 million	1.75 million	Trending News Analyst Forecast Analyst Revision
GLPG Galapagos	$32.91 +1.4%	N/A	$2.14 billion	304,840	441,117	Positive News
CELC Celcuity	$51.57 -0.4%	N/A	$2.02 billion	942,952	2.87 million	Earnings Report Analyst Forecast Short Interest ↑
ADPT Adaptive Biotechnologies	$12.41 -4.8%	N/A	$1.99 billion	2.50 million	2.11 million
BEAM Beam Therapeutics	$17.10 -4.0%	N/A	$1.80 billion	2.72 million	2.44 million
DYN Dyne Therapeutics	$12.33 -0.4%	N/A	$1.76 billion	1.93 million	2.98 million
BCRX BioCryst Pharmaceuticals	$8.38 +0.1%	N/A	$1.76 billion	2.47 million	3.59 million
APGE Apogee Therapeutics	$36.90 -1.0%	N/A	$1.72 billion	298,864	600,852
PHR Phreesia	$29.06 +1.3%	N/A	$1.71 billion	654,417	511,287
TWST Twist Bioscience	$28.02 -0.4%	N/A	$1.70 billion	1.20 million	1.92 million
TXG 10x Genomics	$13.46 +0.7%	N/A	$1.66 billion	2.24 million	3.62 million
IMCR Immunocore	$32.31 -1.7%	N/A	$1.66 billion	193,900	325,831	Positive News
CDTX Cidara Therapeutics	$63.24 -3.0%	N/A	$1.65 billion	450,106	479,321
NVAX Novavax	$9.71 +1.4%	4.26	$1.56 billion	9.47 million	8.00 million	Options Volume Gap Up
WVE WAVE Life Sciences	$9.74 -0.2%	N/A	$1.55 billion	2.14 million	1.64 million
VRDN Viridian Therapeutics	$18.11 -2.3%	N/A	$1.51 billion	654,025	768,401
AZTA Azenta	$30.42 +0.1%	N/A	$1.39 billion	554,011	747,589	Positive News
VERA Vera Therapeutics	$21.80 +1.2%	N/A	$1.37 billion	1.92 million	1.30 million	Positive News
COGT Cogent Biosciences	$12.11 +1.9%	N/A	$1.35 billion	1.46 million	1.75 million	Positive News
EVO Evotec	$3.68 -2.1%	N/A	$1.34 billion	65,144	79,918	Analyst Revision
RDW Redwire	$9.02 +0.9%	N/A	$1.29 billion	4.60 million	5.42 million	Analyst Forecast Gap Down
OCSL Oaktree Specialty Lending	$13.66 +1.3%	24.39	$1.19 billion	536,655	644,019	Positive News
ZYME Zymeworks	$14.05 -2.2%	N/A	$1.08 billion	424,523	434,754	News Coverage Analyst Upgrade
ZYME Zymeworks	$14.05 -2.2%	N/A	$1.06 billion	424,523	534,877
SYRE Spyre Therapeutics	$16.94 -0.1%	N/A	$1.02 billion	394,017	516,072	Positive News
UPB Upstream Bio	$18.02 -4.8%	N/A	$1.02 billion	394,799	540,651	Positive News
IOVA Iovance Biotherapeutics	$2.50 -2.0%	N/A	$922.73 million	8.46 million	25.48 million	Short Interest ↓
URGN Urogen Pharma	$19.40 -1.6%	N/A	$911.86 million	581,893	1.32 million	Analyst Forecast
IMNM Immunome	$10.25 -0.3%	N/A	$894.82 million	478,973	664,745
HQH abrdn Healthcare Investors	$16.57 +0.7%	N/A	$886.03 million	269,877	190,877	Dividend Cut Short Interest ↑
THR Thermon Group	$25.66 +1.8%	16.24	$833.57 million	198,985	193,029
DHC Diversified Healthcare Trust	$3.40 +0.9%	N/A	$813.57 million	483,078	805,696	Positive News
SANA Sana Biotechnology	$3.40 +2.1%	N/A	$791.90 million	4.85 million	6.33 million
DNA Ginkgo Bioworks	$13.79 +4.6%	N/A	$780.25 million	1.73 million	1.84 million
TRNS Transcat	$82.24 +0.9%	57.51	$759.88 million	71,760	82,429	Positive News
TNGX Tango Therapeutics	$7.22 +6.6%	N/A	$753.23 million	2.39 million	1.82 million	Positive News Analyst Forecast
FTRE Fortrea	$7.92 -1.5%	N/A	$730.03 million	1.69 million	2.02 million	Positive News
AMLX Amylyx Pharmaceuticals	$7.99 -0.1%	N/A	$713.34 million	1.30 million	1.01 million	Positive News
RIGL Rigel Pharmaceuticals	$40.07 +1.4%	7.41	$708.70 million	1.14 million	647,588
PROK ProKidney	$2.54 +7.6%	N/A	$690.77 million	2.73 million	3.15 million	Earnings Report Short Interest ↓
DNTH Dianthus Therapeutics	$20.96 +1.1%	N/A	$667.59 million	667,302	326,570	High Trading Volume
VIR Vir Biotechnology	$4.48 -0.9%	N/A	$627.90 million	1.11 million	1.01 million	Positive News
TCPC Blackrock Tcp Capital	$7.06 +0.1%	N/A	$599.51 million	468,684	567,683	Short Interest ↑
TRML Tourmaline Bio	$22.17 -1.8%	N/A	$579.72 million	213,864	212,610	News Coverage Earnings Report Analyst Revision
ORKA Oruka Therapeutics	$15.25 -0.8%	N/A	$575.62 million	113,111	135,628	Analyst Downgrade
TYRA Tyra Biosciences	$10.81 +0.7%	N/A	$569.66 million	124,002	194,242	Positive News Earnings Report Upcoming Earnings
ANAB AnaptysBio	$20.02 -0.6%	N/A	$563.86 million	216,479	522,341
Man Who Called Nvidia at $1.10 Says Buy This Now... (Ad) In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia. Watch Alex's "Next Magnificent Seven" presentation now.
RAPP Rapport Therapeutics	$14.59 -0.7%	N/A	$536.70 million	134,121	162,221	Insider Trade
SEPN Septerna	$11.59 -1.1%	N/A	$522.54 million	249,232	230,135	Upcoming Earnings Analyst Downgrade
ARVN Arvinas	$7.17 +1.1%	N/A	$520.53 million	1.74 million	2.16 million
PRME Prime Medicine	$3.50 -2.0%	N/A	$471.01 million	2.35 million	2.51 million
LAB Standard BioTools	$1.27 +3.3%	N/A	$467.18 million	1.76 million	1.36 million	Analyst Upgrade Gap Up
RGNX REGENXBIO	$8.71 -1.2%	N/A	$445.53 million	449,843	692,483
PRTA Prothena	$8.53 +3.4%	N/A	$444.10 million	1.16 million	1.07 million
WNC Wabash National	$10.72 +0.4%	N/A	$436.81 million	557,540	770,457	Short Interest ↓
PRTC PureTech Health	$19.84 +10.2%	N/A	$434.61 million	606	2,797	News Coverage Short Interest ↓ Gap Up
REPL Replimune Group	$5.33 -4.1%	N/A	$433.99 million	2.81 million	24.42 million	Short Interest ↑ Gap Down

Resources

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.

Top Biotech Stocks: Exploring Innovation Opportunities

Written by Jessica Mitacek | Reviewed by Don Miller

Updated June 6, 2024 | Reviewed on June 6, 2024

Biotech stocks continue to be a robust sector of the stock market. An aging population with increasing healthcare demands, combined with rapidly growing and improving technology, supports the growth of biotech stocks. The biotech industry is highly competitive and incredibly diverse, with a few companies managing to stand out and make a name for themselves.

Biotech stocks can be highly volatile, and some investors choose to diversify their exposure through biotech-focused exchange traded funds (ETFs) or mutual funds to mitigate some of the risks while allowing investors to benefit from the sector's overall growth. Some top ETFs tracking companies in the biotech sector are the SPDR S&P Biotech ETF (NYSEARCA: XBI), iShares Biotechnology ETF (NASDAQ : IBB), and ALPS Medical Breakthroughs ETF (NYSEARCA: SBIO).

Let’s take a look at some of the top biotech companies in the world.

Vertex Pharmaceuticals (NASDAQ: VRTX)

Vertex focuses on treatments for cystic fibrosis and has seen strong growth in recent years. The company ranks highly among biotech companies and is exploring gene editing as a treatment for muscular dystrophy and sickle cell anemia. Vertex’s rapid profit growth makes it an attractive investment.

Regeneron Pharmaceuticals (NASDAQ: REGN)

Regeneron has a robust pipeline of drugs, including successful treatments like EYLEA for eye diseases and Dupixent for autoimmune diseases, as well as promising candidates like odronextamab for follicular lymphoma. The company invests heavily in R&D, leading to breakthroughs in treatments for serious conditions, positioning it as a leader in the biotech industry.

Moderna (NASDAQ: MRNA)

Known for its COVID-19 vaccine, Moderna is developing new vaccines and treatments including a flu/COVID-19 combination vaccine expected by 2025 and an RSV vaccine candidate that could be approved soon. The company is investing heavily in mRNA technology for other vaccines and treatments.

Amgen (NASDAQ: AMGN)

As one of the largest biotech companies, Amgen has a diverse portfolio of drugs for various conditions. The company is valued at over $100 billion and offers a generous dividend yield, making it a stable investment.

BioMarin Pharmaceutical (NASDAQ: BMRN)

BioMarin focuses on rare diseases and gene therapies. Its significant products include Vimizim, Voxzogo, and Roctavian, which have shown substantial sales growth.

Gilead Sciences (NASDAQ: GILD)

A leader in both HIV and liver diseases, Gildead is known for its revolutionary treatment for Hepatitis C released in 2014. The company has a strong pipeline with promising therapies in development, particularly in oncology and virology, which are expected to drive future growth. Gilead has also made strategic acquisitions to bolster its R&D capabilities and expand its market presence.

Legend Biotech (NASDAQ: LEGN)

This clinical-stage biopharma company specializes in cell therapies for cancer. Its breakthrough CAR-T cell therapy, Carvykti, has shown significant efficacy in treating multiple myeloma. In addition, the company has collaborated with Johnson & Johnson’s Janssen unit.

About The Editor

Jessica Mitacek

Associate Editor & Contributing Author

Market Analysis and Research

Learn More

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Biotechnology Stocks

Resources

Biotech Stocks Frequently Asked Questions

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Biotechnology Stocks

Resources

Biotech Stocks Frequently Asked Questions

What Are Biotech Stocks?

What Are the Leading Companies in the Biotech Sector?

How Can I Invest in Biotech Stocks?

What Should I Consider Before Investing in Biotech Stocks?

Top Biotech Stocks: Exploring Innovation Opportunities

Jessica Mitacek

Associate Editor & Contributing Author

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools